ALI PENN: Open Payments
NPI 1962749085 · WAVERLY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 52 payments from 18 companies in 2025. Trend: 2023 $1,376 · 2024 $1,133 · 2025 $961
Food & beverage: $916Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $211 |
| AstraZeneca Pharmaceuticals LP | 6 | $149 |
| Calyxo, Inc. | 1 | $141 |
| Lilly USA, LLC | 5 | $105 |
| Novo Nordisk Inc | 4 | $73 |
| Dexcom, Inc. | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Alkermes, Inc. | 2 | $29 |
| PFIZER INC. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: VRAYLAR, CVAC ASPIRATION SYSTEM, FARXIGA, Dexcom G6 Transmitter, JARDIANCE, Wegovy, MOUNJARO, XIFAXAN.
Industry payments across OH — which companies pay providers there.
